These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 16840420)

  • 1. Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.
    Currie GP; Lee DK; Menzies D; Lipworth BJ
    Chest; 2006 Jul; 130(1):301-2. PubMed ID: 16840420
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of leukotriene antagonists in asthma therapy raised].
    MMW Fortschr Med; 2008 Mar; 150(13):44-5. PubMed ID: 18522358
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interview with Dr. W. Wiebicke, Bremen. To treat early with anti-inflammatory drugs!].
    Wiebicke W
    MMW Fortschr Med; 2002 Feb; 144(8):12-3. PubMed ID: 11910814
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients.
    Virchow JC; Mehta A; Ljungblad L; Mitfessel H
    J Asthma; 2010 Nov; 47(9):986-93. PubMed ID: 20858152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroid therapy in asthma: a balancing act.
    Li JT
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213
    [No Abstract]   [Full Text] [Related]  

  • 8. Montelukast in childhood asthma.
    Mehta PN
    Indian Pediatr; 2000 Nov; 37(11):1201-9. PubMed ID: 11086302
    [No Abstract]   [Full Text] [Related]  

  • 9. [Montelukast in the treatment of mild to moderate persistent asthma].
    Bellecoste V; Devouassoux G; Pacheco Y
    Rev Mal Respir; 2011 Jun; 28(6):706-29. PubMed ID: 21742233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
    Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
    J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukotriene antagonists against bronchial asthma. Not a replacement for steroids].
    MMW Fortschr Med; 1999 Sep; 141(38):56. PubMed ID: 10904622
    [No Abstract]   [Full Text] [Related]  

  • 12. [Leukotriene receptor antagonist effective in chronic asthma].
    Jébrak G
    Presse Med; 1998 Nov; 27(35):1795. PubMed ID: 9850698
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of montelukast in patients with persistent asthma using inhaled corticosteroids plus additional second-line therapy.
    Currie GP; Anderson WJ; Lee DK
    J Allergy Clin Immunol; 2005 Jul; 116(1):230. PubMed ID: 15990804
    [No Abstract]   [Full Text] [Related]  

  • 14. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
    Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
    Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience with montelukast, a leukotriene receptor antagonist, in pediatric patients with asthma].
    Vega López M; Jiménez Ferral R
    Rev Alerg Mex; 2001; 48(5):133-6. PubMed ID: 11759254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS; Campbell D; Barnes PJ
    Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene-receptor antagonists. Role in asthma management.
    D'Urzo AD; Chapman KR
    Can Fam Physician; 2000 Apr; 46():872-9. PubMed ID: 10790819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.
    Deykin A; Wechsler ME; Boushey HA; Chinchilli VM; Kunselman SJ; Craig TJ; DiMango E; Fahy JV; Kraft M; Leone F; Lazarus SC; Lemanske RF; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Israel E;
    Am J Respir Crit Care Med; 2007 Feb; 175(3):228-34. PubMed ID: 16973987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What helps for persistent symptoms of asthma during inhalative steroid therapy?].
    Kroegel C
    Dtsch Med Wochenschr; 2011 Oct; 136(42):2130. PubMed ID: 21990055
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.